Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors

被引:72
作者
Escuret, Vanessa [1 ]
Frobert, Emilie [1 ]
Bouscambert-Duchamp, Maude [1 ]
Sabatier, Murielle [1 ]
Grog, Isidore [3 ]
Valette, Martine [2 ]
Lina, Bruno [1 ,2 ]
Morfin, Florence [1 ]
Ferraris, Olivier [1 ]
机构
[1] Univ Lyon 1, CNRS, FRE 3011, F-69372 Lyon 08, France
[2] Ctr Biol Est, Hospices Civils Lyon, CNR Virus Influenza France Sud, F-69677 Bron, France
[3] OpenRome, GROG, F-75018 Paris, France
关键词
influenza; neuraminidase inhibitors; resistance; systematic monitoring;
D O I
10.1016/j.jcv.2007.10.019
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Neuraminidase inhibitors (NAIs) have been used since 2005 in France. Objective: Influenza viruses isolated in hospital and community cases in winter 2005-2006 were evaluated for their sensitivity to NAIs. Study design: Isolates were tested in duplicate with a fluorescence-based neuraminidase assay. The IC50 for oseltamivir or zanamivir was calculated for each strain. Mean IC50 (+/-S.D.) are expressed in nM. Viruses with IC50 superior or very superior to the upper limit (mean IC50 + 2.5 S.D.) were considered as outliers or resistant viruses, respectively. HA and NA genes for outliers, resistant strains and for a few sensitive strains were sequenced. Results: Out of 225 B isolates, one was found resistant to both oseltamivir and zanamivir with a D197Y mutation in NA and eight isolates were outliers for oseltamivir and/or zanamivir. Out of 151 A (H1N1) isolates, one was found resistant to oseltamivir but sensitive to zanamivir with a H275Y mutation in NA, two isolates were resistant to zanamivir and three isolates were outliers for oseltamivir and/or zanamivir. New mutations were detected in outliers compared to sensitive viruses. Conclusion: Resistant influenza strains to NAIs are circulating at a stable and low level of 1% since the introduction of NAIs in clinical practice. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:25 / 28
页数:4
相关论文
共 18 条
[1]   Brief report - Oseltamivir resistance during treatment of influenza A (H5N1) infection [J].
de Jong, MD ;
Thanh, TT ;
Khanh, TH ;
Hien, VM ;
Smith, GJD ;
Chau, NV ;
Cam, BV ;
Qui, PT ;
Ha, DQ ;
Guan, Y ;
Peiris, JSM ;
Hien, TT ;
Farrar, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (25) :2667-2672
[2]   Sensitivity performed of influenza viruses to zanamivir and oseltamivir: A study on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice [J].
Ferraris, O ;
Kessler, N ;
Lina, B .
ANTIVIRAL RESEARCH, 2005, 68 (01) :43-48
[3]   Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors [J].
Gubareva, LV .
VIRUS RESEARCH, 2004, 103 (1-2) :199-203
[4]   Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir [J].
Gubareva, LV ;
Kaiser, L ;
Matrosovich, MN ;
Soo-Hoo, Y ;
Hayden, FG .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (04) :523-531
[5]   Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors [J].
Hatakeyama, Shuji ;
Sugaya, Norio ;
Ito, Mutsumi ;
Yamazaki, Masahiko ;
Ichikawa, Masataka ;
Kimura, Kazuhiro ;
Kiso, Maki ;
Shimizu, Hideaki ;
Kawakami, Chiharu ;
Koike, Kazuhiko ;
Mitamura, Keiko ;
Kawaoka, Yoshihiro .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (13) :1435-1442
[6]   Influenza viruses resistant to the antiviral drug oseltamivir: Transmission studies in ferrets [J].
Herlocher, ML ;
Truscon, R ;
Elias, S ;
Yen, HL ;
Roberts, NA ;
Ohmit, SE ;
Monto, AS .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (09) :1627-1630
[7]   Rescue of influenza B virus from eight plasmids [J].
Hoffmann, E ;
Mahmood, K ;
Yang, CF ;
Webster, RG ;
Greenberg, HB ;
Kemble, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (17) :11411-11416
[8]   Universal primer set for the full-length amplification of all influenza A viruses [J].
Hoffmann, E ;
Stech, J ;
Guan, Y ;
Webster, RG ;
Perez, DR .
ARCHIVES OF VIROLOGY, 2001, 146 (12) :2275-2289
[9]   Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient [J].
Hurt, AC ;
Iannello, P ;
Jachno, K ;
Komadina, N ;
Hampson, AW ;
Barr, IG ;
McKimm-Breschkin, JL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (05) :1872-1874
[10]   Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs [J].
Hurt, AC ;
McKimm-Breschkin, JL ;
McDonald, M ;
Barr, IG ;
Komadina, N ;
Hampson, AW .
VIRUS RESEARCH, 2004, 103 (1-2) :205-211